IGC Pharma, Inc.
IGC
$0.4514
$0.061415.74%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.60M | -1.20M | -1.83M | -1.72M | -2.38M |
| Total Depreciation and Amortization | 141.00K | 154.00K | 157.00K | 145.00K | 162.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 428.00K | 609.00K | 381.00K | 388.00K | 402.00K |
| Change in Net Operating Assets | -377.00K | -296.00K | -26.00K | 188.00K | 62.00K |
| Cash from Operations | -1.41M | -730.00K | -1.32M | -996.00K | -1.75M |
| Capital Expenditure | -8.00K | -18.00K | -27.00K | -29.00K | -38.00K |
| Sale of Property, Plant, and Equipment | 702.00K | 24.00K | 0.00 | 16.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -114.00K | -148.00K | -77.00K | -52.00K | -93.00K |
| Cash from Investing | 580.00K | -142.00K | -104.00K | -65.00K | -131.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.00K | 0.00 | -1.00K | -1.00K | -1.00K |
| Issuance of Common Stock | 852.00K | 805.00K | 346.00K | 795.00K | 2.51M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 851.00K | 805.00K | 345.00K | 794.00K | 2.51M |
| Foreign Exchange rate Adjustments | 25.00K | 2.00K | 0.00 | -11.00K | 2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 49.00K | -65.00K | -1.08M | -278.00K | 626.00K |